Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
Co-FounderDr. Rachel E. Haurwitz Ph.D.
Chief Financial OfficerMr. Sriram Ryali M.B.A.
J.D.Ms. Barbara G. McClung Esq.
Co-founder & Member of Scientific Advisory BoardDr. Jennifer A. Doudna Ph.D.
Interim Principal Accounting Officer & ControllerMr. Ryan Fischesser
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, alerts, and much more.